Retrial Begins In Original Testosterone MDL Bellwether

Law360, Chicago (March 7, 2018, 9:21 PM EST) -- Attorneys for a man who had a heart attack while taking AbbVie Inc.’s testosterone replacement therapy product AndroGel opened the retrial of the man’s claims against the pharmaceutical company Wednesday, telling an Illinois federal jury AbbVie didn’t tell his doctor about the drug’s risks.

Jesse Mitchell didn’t know the risk he was taking when he used AndroGel because AbbVie hadn’t properly tested the product or warned doctors about its possible connection to heart attacks, his attorney told the jury during opening arguments in the trial for...
To view the full article, register now.



Case Information

Case Title

Mitchell et al v. AbbVie, Inc. et al

Case Number



Illinois Northern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)


Honorable Matthew F. Kennelly

Date Filed

November 17, 2014

Law Firms


Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.